G. Langford

发表

Virus safety in xenotransplantation: first exploratory in vivo studies in small laboratory animals and non-human primates.

R. Kurth, H. Schuurman, J. Denner, 2002, Transplant immunology.

Transgenic pigs expressing human CD59, in combination with human membrane cofactor protein and human decay‐accelerating factor

E. Mcinnes, L. Copeman, G. Langford, 2005, Xenotransplantation.

Orthotopic heart transplantation in a transgenic pig-to-primate model.

M. Goddard, J. Wallwork, M. Schmoeckel, 1998, Transplantation.

Monitoring xenotransplant recipients for infection by PERV.

X. M. Fernández-Suárez, G. Langford, C. Herring, 2001, Clinical biochemistry.

Life-supporting pig-to-baboon heart xenotransplantation.

J. Wallwork, E. Cozzi, J. Dunning, 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER ASSOCIATED WITH PRIMATE GAMMA‐HERPESVIRUS IN CYNOMOLGUS MONKEYS USED IN PIG‐TO‐PRIMATE RENAL XENOTRANSPLANTATION AND PRIMATE RENAL ALLOTRANSPLANTATION

M. Goddard, H. Schuurman, R. Jarrett, 2002, Transplantation.

Reduced Sensitivity to Human Serum Inactivation of Enveloped Viruses Produced by Pig Cells Transgenic for Human CD55 or Deficient for the Galactosyl-α(1-3) Galactosyl Epitope

R. Weiss, Y. Takeuchi, C. Patience, 2004, Journal of Virology.

Production of pigs transgenic for human decay accelerating factor.

E. Cozzi, D. White, N. Yannoutsos, 1994, Transplantation proceedings.

Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors.

P. Friend, S. Thiru, M. Tolan, 1998, Transplantation.

Characterization of pigs transgenic for human decay-accelerating factor.

M. O'connell, E. Cozzi, A. Tucker, 1997, Transplantation.

Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group.

W. Heneine, D. Onions, W. Switzer, 1999, Science.

Analysis of transgene integration sites in transgenic pigs by fluorescence in situ hybridization

D. White, G. Langford, H. Kuipers, 1997, Transgenic Research.

Effect of Transgenic Expression of Human Decay—Accelerating Factor on the Inhibition of Hyperacute Rejection of Pig Organs

J. Wallwork, D. White, E. Cozzi, 1997 .

Pig-to-primate cardiac xenotransplantation and cyclophosphamide therapy.

J. Wallwork, E. Cozzi, J. Dunning, 1997, Transplantation proceedings.

The porcine endogenous retrovirus long terminal repeat contains a single nucleotide polymorphism that confers distinct differences in estrogen receptor binding affinity between PERV A and PERV B/C subtypes.

G. Quinn, G. Langford, 2001, Virology.

ACTIVATION OF PRIMARY PORCINE ENDOTHELIAL CELLS INDUCES RELEASE OF PORCINE ENDOGENOUS RETROVIRUSES

X. M. Fernández-Suárez, L. Copeman, G. Langford, 2004, Transplantation.

The control of hyperacute rejection by genetic engineering of the donor species

J. Wallwork, E. Cozzi, D. White, 1995, Eye.

Longitudinal analysis of the expression of human decay accelerating factor (HDAF) on lymphocytes, in the plasma, and in the skin biopsies of transgenic pigs

A. Levy, D. White, G. Langford, 1996 .

Analysis of patients treated with living pig tissue for evidence of infection by porcine endogenous retroviruses.

X. M. Fernández-Suárez, K. Paradis, G. Langford, 2001, Trends in cardiovascular medicine.

Mapping Full-Length Porcine Endogenous Retroviruses in a Large White Pig

N. Parsons, A. Brawley, X. M. Fernández-Suárez, 2001, Journal of Virology.

In vivo analysis of porcine endogenous retrovirus expression in transgenic pigs.

X. M. Fernández-Suárez, A. Shepherd, D. Onions, 2001, Transplantation.

Production and characterization of a pig line transgenic for human membrane cofactor protein

L. Copeman, G. Langford, Chun-yan Zhou, 2002, Xenotransplantation.

TISSUE EXPRESSION OF HUMAN COMPLEMENT INHIBITOR, DECAY‐ACCELERATING FACTOR, IN TRANSGENIC PIGS A POTENTIAL APPROACH FOR PREVENTING XENOGRAFT REJECTION

N. Cary, J. Wallwork, D. White, 1995, Transplantation.

Expression of human DAF and MCP on pig endothelial cells protects from human complement.

E. Cozzi, D. White, N. Yannoutsos, 1995, Transplantation proceedings.

Transgenic pigs and xenotransplantation

D. White, E. Cozzi, N. Yannoutsos, 1995 .

Antiretroviral Agents Inhibit Infection of Human Cells by Porcine Endogenous Retroviruses

E. Otto, C. Lockey, Z. Long, 2000, Antimicrobial Agents and Chemotherapy.

Comparative analysis of human DAF expression in the tissues of transgenic pigs and man.

E. Cozzi, A. Tucker, D. White, 1995, Transplantation proceedings.

Endothelial expression of human decay accelerating factor in transgenic pig tissue: a potential approach for human complement inactivation in discordant xenografts.

N. Cary, J. Wallwork, J. Horsley, 1995, Transplantation proceedings.

Production of pigs transgenic for human regulators of complement activation using YAC technology.

E. Cozzi, D. White, N. Yannoutsos, 1996, Transplantation proceedings.

Transplantation of normal and DAF-transgenic fetal pig pancreas into cynomolgus monkeys.

M. Koulmanda, E. Cozzi, D. White, 1997, Transplantation proceedings.

Expression of human decay accelerating factor in transgenic pigs.

E. Cozzi, D. White, N. Yannoutsos, 1994, Transplantation proceedings.

Production of pigs transgenic for human regulators of complement activation.

E. Cozzi, D. White, N. Yannoutsos, 1995, Transplantation proceedings.

Genetic engineering of the donor species to control hyperacute xenograft rejection.

J. Wallwork, E. Cozzi, D. White, 1995, Advances in nephrology from the Necker Hospital.